Hartmut S.
- Country
- Germany
- Department
- N/A
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Open‑Label Study of Switching to Lenacapavir Combined with Teropavimab and Zinlirvimab in Virologically Suppressed Adults with HIV‑1
Data & Insights
Has run more than one trial at 127 of 207 partner sites.
Specializations
Hepatology Focus
This investigator specializes in the treatment of chronic hepatitis B infection, with particular emphasis on innovative therapeutic approaches. Their research concentrates on evaluating long-term treatment responses and exploring potential functional cure strategies.
- Chronic HBV Management
- Viral Hepatitis Treatment
- Long-term Patient Monitoring
The investigator's work encompasses comprehensive patient care in chronic hepatitis B, focusing on sustained therapeutic outcomes.
Treatment Innovation
Active involvement in studying novel therapeutic agents for hepatitis B treatment, with specific interest in investigating treatment durability and response patterns in patients with chronic HBV infection.
- Antiviral Therapeutics
- Treatment Response Assessment
- Clinical Efficacy Studies
Their research extends to evaluating treatment effectiveness in patients under various therapeutic regimens.
Patient Care Excellence
Specializes in long-term patient follow-up and monitoring of treatment outcomes in chronic hepatitis B patients. Focuses on comprehensive evaluation of therapeutic responses and maintaining sustained clinical benefits.
- Treatment Response Monitoring
- Patient Outcome Assessment
- Clinical Response Evaluation
Emphasis on tracking and analyzing long-term treatment effectiveness in hepatitis B patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.